跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Koact 625 Film-coated Tablet 500 mg/125 mg - HSA Drug Approval Details
Approvals
/
HSA
/
Koact 625 Film-coated Tablet 500 mg/125 mg
Approved
THERAPEUTIC
Koact 625 Film-coated Tablet 500 mg/125 mg
Aurobindo Pharma Limited (Unit XII)
🇸🇬 Health Sciences Authority
Approval Date
Feb 22, 2013
Approval ID
a2b0be3915eb7808
Company
Aurobindo Pharma Limited (Unit XII)
Type
Therapeutic
Approval Details
Approval Id
a2b0be3915eb7808
Drug Name
Koact 625 Film-coated Tablet 500 mg/125 mg
Product Name
Koact 625 Film-coated Tablet 500 mg/125 mg
Approval Number
SIN14317P
Approval Date
2013-02-22
Registrant
APOTHECA MARKETING PTE LTD
Licence Holder
APOTHECA MARKETING PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
J01CR02
Atc Item Name
amoxicillin and beta-lactamase inhibitor
Pharma Manufacturer Name
APOTHECA MARKETING PTE LTD
Company Detail Path
/organization/apotheca-marketing-pte-ltd
Active Ingredients
Potassium Clavulanate 148.91 mg eqv Clavulanic Acid
125 mg
Amoxicillin Trihydrate 573.40 mg eqv Amoxicillin
500 mg
Amoxicillin Trihydrate 573.40 mg eqv Amoxicillin
500 mg
Potassium Clavulanate 148.91 mg eqv Clavulanic Acid
125 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 22, 2013
Approval ID
a2b0be3915eb7808
Type
Therapeutic
Back to HSA Approvals
